13 insiders reported 55 Form 4 transactions for Aura Biosciences, Inc. (AURA) over the past 18 months (most recent 2026-07-01). Recent activity: Kilroy Conor (See Remarks) Buy 14,858 shares, Gibney Anthony S (See Remarks) Sell 12,824 shares, Holles Natalie C. (See Remarks) Buy 600,118 shares, Holles Natalie C. (See Remarks) Buy 553,844 shares, Matrix Capital Management Company, LP (Insider) Sell 6.9M shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Kilroy Conor | See Remarks | Buy | 14,858 | $0 |
| 2026-06-16 | Gibney Anthony S | See Remarks | Sell | 12,824 | $82,330 |
| 2026-05-19 | Holles Natalie C. | See Remarks | Buy | 600,118 | $0 |
| 2026-05-19 | Holles Natalie C. | See Remarks | Buy | 553,844 | $0 |
| 2026-05-11 | Matrix Capital Management Company, LP | Insider | Sell | 6.9M | $39.0M |
| 2026-05-11 | GOEL DAVID E. | Insider | Sell | 6.9M | $39.0M |
| 2026-04-16 | Kilroy Conor | See Remarks | Sell | 11,738 | $82,401 |
| 2026-03-03 | de los Pinos Elisabet | See Remarks | Buy | 166,000 | $0 |
| 2026-03-03 | Hopkins Janet Jill | Chief Medical Officer | Buy | 89,056 | $0 |
| 2026-03-03 | Plavsic Mark | Chief Technology Officer | Buy | 62,339 | $0 |
| 2026-03-03 | Kilroy Conor | See Remarks | Buy | 62,339 | $0 |
| 2026-03-03 | Elazzouzi Amy | Senior Vice President, Finance | Buy | 44,528 | $0 |
| 2026-03-03 | Gibney Anthony S | See Remarks | Buy | 71,245 | $0 |
| 2026-02-17 | Plavsic Mark | Chief Technology Officer | Sell | 15,890 | $80,244 |
| 2026-02-17 | Elazzouzi Amy | Senior Vice President, Finance | Sell | 8,549 | $43,258 |
| 2026-02-17 | de los Pinos Elisabet | See Remarks | Sell | 47,648 | $241,099 |
| 2026-02-17 | Hopkins Janet Jill | Chief Medical Officer | Sell | 20,401 | $103,229 |
| 2026-02-17 | Kilroy Conor | See Remarks | Sell | 12,079 | $60,999 |
| 2026-01-20 | de los Pinos Elisabet | See Remarks | Sell | 16,928 | $82,270 |
| 2026-01-20 | Elazzouzi Amy | Senior Vice President, Finance | Sell | 1,581 | $7,684 |
| 2025-11-17 | Hopkins Janet Jill | Chief Medical Officer | Sell | 17,109 | $92,731 |
| 2025-10-29 | Elazzouzi Amy | Senior Vice President, Finance | Sell | 896 | $5,690 |
| 2025-10-29 | de los Pinos Elisabet | See Remarks | Sell | 9,049 | $57,461 |
| 2025-10-16 | Plavsic Mark | Chief Technology Officer | Sell | 12,169 | $77,273 |
| 2025-08-18 | Elazzouzi Amy | Senior Vice President, Finance | Buy | 2,554 | $12,949 |
Source: SEC Form 4 filings · as of 2026-07-01